Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Knight Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Knight Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 11
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Knight Therapeutics Acquires ATryn and Photofrin from Orphan Canada 14
Partnerships 16
3D Signatures and Plicit Capital Enters into Licensing Agreement with Knight Therapeutics 16
Knight Therapeutics Enters into Licensing Agreement with Pro Bono Bio 17
Knight Therapeutics Expands Distribution Agreement with Ember Therapeutics 18
Knight Therapeutics Enters into Distribution Agreement with Akorn 19
Alimera Sciences Enters into Distribution Agreement with Knight Therapeutics 20
Licensing Agreements 21
Knight Therapeutics Enters into Licensing Agreement with Jaguar Health 21
Knight Therapeutics Enters into Licensing Agreement with TherapeuticsMD 22
Knight Therapeutics Enters into Licensing Agreement with Ardelyx 23
Knight Therapeutics Enters into Licensing Agreement with AstraZeneca for Movantik 24
SIFI Enters into Licensing Agreement with Knight Therapeutics 25
Knight Therapeutics Enters into Licensing Agreement with Medimetriks Pharma 26
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 27
Knight Therapeutics Enters into Licensing Agreement with INTEGA Skin Sciences 28
Knight Therapeutics Enters into Licensing Agreement with 60 Degrees Pharma 29
Knight Therapeutics Enters into Licensing Agreement with Antibe Therapeutics 30
Knight Therapeutics Enters into Licensing Agreement with Advaxis 31
Equity Offering 32
Knight Therapeutics to Raise USD65 Million in Private Placement of Shares 32
Knight Therapeutics Raises USD176 Million in Public Offering of Shares 34
Advaxis Raises USD25 Million in Private Placement of Shares 36
Knight Therapeutics Raises USD76.5 Million in Public Offering of Shares 38
Knight Therapeutics Completes Private Placement Of Warrants For US$160 Million 39
Asset Transactions 40
Synergy Strips to Acquire US Rights of Neuragen from Knight Therapeutics for USD1.2 Million 40
Acquisition 41
Knight Therapeutics Acquires 4% Stake in Crescita Therapeutics 41
Knight Therapeutics Acquires 16% of Stake in Pediapharm 42
Knight Therapeutics Acquires 28.3% Stake in Medison Biotech for USD60.3 Million 43
Knight Therapeutics Acquires NeurAxon for USD1.5 Million 44
Knight Therapeutics Inc – Key Competitors 45
Knight Therapeutics Inc – Key Employees 46
Knight Therapeutics Inc – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 48
Financial Announcements 48
May 10, 2018: Knight Reports First Quarter 2018 Results 48
Mar 15, 2018: Knight Reports 2017 Fourth Quarter and Year End Results 49
Nov 09, 2017: Knight Reports Third Quarter 2017 Results 51
Aug 10, 2017: Knight Reports Second Quarter 2017 Results 53
May 11, 2017: Knight Reports First Quarter 2017 Results 55
Mar 16, 2017: Knight Reports Fourth Quarter and Year-Ended December 31, 2016 Results 56
Corporate Communications 57
Oct 10, 2017: Knight Announces Changing of the Finance Guard 57
Feb 23, 2017: Knight Therapeutics Announces Board Change 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Knight Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Knight Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Knight Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 11
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Knight Therapeutics Acquires ATryn and Photofrin from Orphan Canada 14
3D Signatures and Plicit Capital Enters into Licensing Agreement with Knight Therapeutics 16
Knight Therapeutics Enters into Licensing Agreement with Pro Bono Bio 17
Knight Therapeutics Expands Distribution Agreement with Ember Therapeutics 18
Knight Therapeutics Enters into Distribution Agreement with Akorn 19
Alimera Sciences Enters into Distribution Agreement with Knight Therapeutics 20
Knight Therapeutics Enters into Licensing Agreement with Jaguar Health 21
Knight Therapeutics Enters into Licensing Agreement with TherapeuticsMD 22
Knight Therapeutics Enters into Licensing Agreement with Ardelyx 23
Knight Therapeutics Enters into Licensing Agreement with AstraZeneca for Movantik 24
SIFI Enters into Licensing Agreement with Knight Therapeutics 25
Knight Therapeutics Enters into Licensing Agreement with Medimetriks Pharma 26
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 27
Knight Therapeutics Enters into Licensing Agreement with INTEGA Skin Sciences 28
Knight Therapeutics Enters into Licensing Agreement with 60 Degrees Pharma 29
Knight Therapeutics Enters into Licensing Agreement with Antibe Therapeutics 30
Knight Therapeutics Enters into Licensing Agreement with Advaxis 31
Knight Therapeutics to Raise USD65 Million in Private Placement of Shares 32
Knight Therapeutics Raises USD176 Million in Public Offering of Shares 34
Advaxis Raises USD25 Million in Private Placement of Shares 36
Knight Therapeutics Raises USD76.5 Million in Public Offering of Shares 38
Knight Therapeutics Completes Private Placement Of Warrants For US$160 Million 39
Synergy Strips to Acquire US Rights of Neuragen from Knight Therapeutics for USD1.2 Million 40
Knight Therapeutics Acquires 4% Stake in Crescita Therapeutics 41
Knight Therapeutics Acquires 16% of Stake in Pediapharm 42
Knight Therapeutics Acquires 28.3% Stake in Medison Biotech for USD60.3 Million 43
Knight Therapeutics Acquires NeurAxon for USD1.5 Million 44
Knight Therapeutics Inc, Key Competitors 45
Knight Therapeutics Inc, Key Employees 46
Knight Therapeutics Inc, Subsidiaries 47
List of Figures
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Knight Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Knight Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 11